González David Andrés, Finley John-Christopher A, Patel Samantha Evy Schoeneman, Soble Jason R
Department of Neurological Sciences (DAG, SESP), Rush University Medical Center, Chicago, IL, USA.
Department of Psychiatry & Behavioral Sciences (JCAF), Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Am J Geriatr Psychiatry. 2025 May;33(5):524-534. doi: 10.1016/j.jagp.2024.10.014. Epub 2024 Oct 28.
To improve assessment of neuropsychiatric symptoms (NPS) by expanding the measurement properties of the Neuropsychiatric Inventory Questionnaire (NPI-Q).
Multicenter, longitudinal observational study.
Several Alzheimer's Disease Research Centers (ADRCs).
Individuals (n = 45,274) who presented to an ADRC with a collateral and completed the NPI-Q.
The NPI-Q total severity score, four NPI-Q subscales, dementia stage, expert NPS rating, consensus rating of dementia syndrome, global cognitive screening, collateral rating of daily functioning, and self-rating of depression.
There was strong evidence of criterion validity with both dementia stage and expert NPS rating for the NPI-Q total severity index, which informed cutoffs and interpretive ranges. Furthermore, subscales had adequate classification of dementia syndromes and appropriate convergent relationships with cognition, daily functioning, and mood. There was good-to-excellent evidence of reliability for the NPI-Q total severity index over several years, and subscales had adequate-to-good reliability.
This is the first study to provide empirically established cutoffs, interpretive ranges, and evidence of reliability over a period longer than a month on the NPI-Q and its subscales. This will improve assessment of NPS in clinical and research contexts.
Neuropsychiatric symptoms of neurodegeneration are increasingly understood as early disease markers with tremendous functional impact later in disease, but are often missed or misdiagnosed. The most common measure of these symptoms, the Neuropsychiatric Inventory Questionnaire (NPI-Q), does not have clinically actionable guidance, which this article provided. We established cutscores for several conditions and test-retest reliability over longer periods for the total score and subscales using a multicenter database.
通过扩展神经精神症状问卷(NPI-Q)的测量属性来改进对神经精神症状(NPS)的评估。
多中心纵向观察性研究。
多个阿尔茨海默病研究中心(ADRCs)。
向ADRC就诊并由他人陪同完成NPI-Q的个体(n = 45274)。
NPI-Q总严重程度评分、四个NPI-Q分量表、痴呆阶段、专家对NPS的评分、痴呆综合征的共识评分、整体认知筛查、他人对日常功能的评分以及抑郁自评。
有强有力的证据表明,NPI-Q总严重程度指数在痴呆阶段和专家对NPS的评分方面均具有标准效度,这为临界值和解释范围提供了依据。此外,分量表对痴呆综合征有充分的分类,并且与认知、日常功能和情绪有适当的聚合关系。有充分到极好的证据表明NPI-Q总严重程度指数在数年时间内具有可靠性,分量表具有足够到良好的可靠性。
这是第一项提供基于经验确定的临界值、解释范围以及超过一个月时间内NPI-Q及其分量表可靠性证据的研究。这将改善临床和研究环境中对NPS的评估。
神经退行性疾病的神经精神症状越来越被视为疾病早期标志物,对疾病后期功能有巨大影响,但常常被漏诊或误诊。这些症状最常用的测量工具——神经精神症状问卷(NPI-Q),没有本文所提供的临床可操作指导。我们使用多中心数据库为几种情况建立了临界值,并对总分和分量表在更长时间段内的重测可靠性进行了测试。